600252 中恒集团
已收盘 06-12 15:00:00
资讯
新帖
简况
中恒集团最新公告:控股孙公司获两项医疗器械注册证
证券之星 · 06-12 18:09
中恒集团最新公告:控股孙公司获两项医疗器械注册证
中恒集团:已暂缓莱美药业部分股份转让事项的公开征集程序
证券之星 · 06-09
中恒集团:已暂缓莱美药业部分股份转让事项的公开征集程序
中恒集团:公司内部控制流程在日常执行中发现了个别一般缺陷
证券之星 · 06-09
中恒集团:公司内部控制流程在日常执行中发现了个别一般缺陷
中恒集团:根据2025年年度报告,公司其他应收款同比减少
证券之星 · 06-09
中恒集团:根据2025年年度报告,公司其他应收款同比减少
中恒集团:截至目前,公司未触及《上海证券交易所股票上市规则》规定的退市情形
证券之星 · 06-09
中恒集团:截至目前,公司未触及《上海证券交易所股票上市规则》规定的退市情形
中恒集团:公司暂未获得更多信息
证券之星 · 06-09
中恒集团:公司暂未获得更多信息
每周股票复盘:中恒集团(600252)孙公司土地收储获息417万
证券之星 · 06-07
每周股票复盘:中恒集团(600252)孙公司土地收储获息417万
每周股票复盘:中恒集团(600252)提名新董事候选人
证券之星 · 05-31
每周股票复盘:中恒集团(600252)提名新董事候选人
中恒集团(600252)披露董事候选人提名公告,5月27日股价下跌1.8%
证券之星 · 05-27
中恒集团(600252)披露董事候选人提名公告,5月27日股价下跌1.8%
每周股票复盘:中恒集团(600252)回应ST风险及创新药进展
证券之星 · 05-24
每周股票复盘:中恒集团(600252)回应ST风险及创新药进展
股市必读:中恒集团(600252)5月20日披露最新机构调研信息
证券之星 · 05-21
股市必读:中恒集团(600252)5月20日披露最新机构调研信息
中恒集团(600252)披露梧州制药(香港)公司完成注销公告,5月20日股价下跌2.17%
证券之星 · 05-20
中恒集团(600252)披露梧州制药(香港)公司完成注销公告,5月20日股价下跌2.17%
中恒集团(600252)披露关于提名董事候选人的公告,5月19日股价上涨0.88%
证券之星 · 05-19
中恒集团(600252)披露关于提名董事候选人的公告,5月19日股价上涨0.88%
中恒集团最新公告:控股孙公司获醋酸曲普瑞林原料药上市批准
证券之星 · 05-15
中恒集团最新公告:控股孙公司获醋酸曲普瑞林原料药上市批准
股市必读:中恒集团一季报 - 第一季度单季净利润同比下降292.41%
证券之星 · 05-06
股市必读:中恒集团一季报 - 第一季度单季净利润同比下降292.41%
每周股票复盘:中恒集团(600252)一季度净亏损3353万
证券之星 · 05-02
每周股票复盘:中恒集团(600252)一季度净亏损3353万
中恒集团(600252)3月31日股东户数11.9万户,较上期增加0.16%
证券之星 · 04-30
中恒集团(600252)3月31日股东户数11.9万户,较上期增加0.16%
图解中恒集团一季报:第一季度单季净利润同比下降292.41%
证券之星 · 04-30
图解中恒集团一季报:第一季度单季净利润同比下降292.41%
每周股票复盘:中恒集团(600252)完成力合中恒医药基金清算注销
证券之星 · 04-26
每周股票复盘:中恒集团(600252)完成力合中恒医药基金清算注销
中恒集团(600252)披露广西力合中恒医药投资合伙企业完成清算注销公告,4月23日股价下跌0.8%
证券之星 · 04-23
中恒集团(600252)披露广西力合中恒医药投资合伙企业完成清算注销公告,4月23日股价下跌0.8%
加载更多
公司概况
公司名称:
广西梧州中恒集团股份有限公司
所属行业:
医药制造业
上市日期:
2000-11-30
主营业务:
广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。公司荣获华夏医学科学技术奖科技进步奖三等奖、中国中西医结合学会科学技术奖三等奖、广西科技进步奖二等奖各1项,培育1家广西“专精特新”企业,研发综合实力再提升。
发行价格:
5.25
{"stockData":{"symbol":"600252","market":"SH","secType":"STK","nameCN":"中恒集团","latestPrice":2.16,"timestamp":1781247600000,"preClose":2.11,"halted":0,"volume":28729117,"delay":0,"changeRate":0.0237,"floatShares":3184000000,"shares":3184000000,"eps":-0.1282,"marketStatus":"已收盘","change":0.05,"latestTime":"06-12 15:00:00","open":2.12,"high":2.17,"low":2.1,"amount":61568200,"amplitude":0.0332,"askPrice":2.17,"askSize":21605,"bidPrice":2.16,"bidSize":7856,"shortable":0,"etf":0,"ttmEps":-0.1282,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"adjPreClose":2.11,"symbolType":"stock","openAndCloseTimeList":[[1781227800000,1781235000000],[1781240400000,1781247600000]],"highLimit":2.32,"lowLimit":1.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3184163070,"isCdr":false,"pbRate":1.31,"roa":"--","roe":"--","epsLYR":-0.1144,"committee":-0.231853,"marketValue":6878000000,"turnoverRate":0.009,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-06-15。","floatMarketCap":6878000000},"requestUrl":"/m/hq/s/600252/","defaultTab":"news","newsList":[{"id":"2642264164","title":"中恒集团最新公告:控股孙公司获两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2642264164","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642264164?lang=zh_cn&edition=full","pubTime":"2026-06-12 18:09","pubTimestamp":1781258984,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称,公司控股孙公司海南莱美医疗器械有限公司收到海南省药品监督管理局颁发的麻醉视频喉镜及一次性使用喉镜片两项《医疗器械注册证》,有效期至2031年6月2日。该产品用于指引医护人员准确进行气道插管,有助于丰富公司医疗器械产品种类,提升综合竞争力,但实际销售情况取决于市场推广效果,对业绩影响尚不确定。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200028766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","09996","BK0015","BK0239","159883","BK0028","BK1574","BK1583","BK1100","BK0188","BK0012","600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642546543","title":"中恒集团:已暂缓莱美药业部分股份转让事项的公开征集程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2642546543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642546543?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:12","pubTimestamp":1780996329,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团(600252)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:什么时候能把莱美药业这个包袱卖了?中恒集团回复:公司已暂缓莱美药业部分股份转让事项的公开征集程序,相关事项正有序推进中,公司将根据该事项进展履行信息披露义务。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900027898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0070","BK0077","600252","BK0015","BK0239","300006","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642976463","title":"中恒集团:公司内部控制流程在日常执行中发现了个别一般缺陷","url":"https://stock-news.laohu8.com/highlight/detail?id=2642976463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642976463?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:42","pubTimestamp":1780994541,"startTime":"0","endTime":"0","summary":"中恒集团回复:1.公司内部控制流程在日常执行中发现了个别一般缺陷,如,在本期发现部分业务用总额法确认依据不足,但已根据《企业会计准则》及时追溯调整并履行信息披露业务,其可能导致的风险均在可控范围内,未对公司内部控制体系整体运行及财务报告信息的真实性、准确性、完整性构成实质性影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900027026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600252","BK0077","BK0028","BK0012","BK0188","BK0015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463363","title":"中恒集团:根据2025年年度报告,公司其他应收款同比减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642463363?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:36","pubTimestamp":1780994169,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团(600252)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:报告期末,你公司其他应收款占总资产的比例高达6.06%。请问公司其他应收款账大幅增加的原因,是否存在资金占用的情形?中恒集团回复:根据2025年年度报告,公司其他应收款同比减少。公司不涉及非经营性资金占用。谢谢您的建议与关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900026830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0015","BK0188","BK0012","600252","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642635184","title":"中恒集团:截至目前,公司未触及《上海证券交易所股票上市规则》规定的退市情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2642635184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642635184?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:33","pubTimestamp":1780994012,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团(600252)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司一步步滑向退市的深渊,请问作为公司的管理层你们有什么办法吗?中恒集团回复:您好,截至目前,公司未触及《上海证券交易所股票上市规则》规定的退市情形。公司将聚焦主业,提升经营质量,努力提升公司内在价值,为股东创造更好的回报,同时强化信息披露与投资者沟通,择机运用资本运作等多种工具,促进价值合理反映,以推动市值与内在价值相匹配。谢谢您的建议与关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900026761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600252","BK0015","BK0188","BK0012","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463512","title":"中恒集团:公司暂未获得更多信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642463512?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:33","pubTimestamp":1780994008,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团(600252)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问:现在医药市场环境已经变了,公司是不是应该考虑把医药资产跟大股东的矿业资产或者直接把药业资产直接置换大股东的金融资产进行转型成矿业股或者是金融投资股中恒集团回复:公司暂未获得更多信息。若相关事项达到信息披露标准,公司将及时履行信息披露义务。谢谢您的建议与关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900026759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0015","BK0239","BK0077","600252","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641278681","title":"每周股票复盘:中恒集团(600252)孙公司土地收储获息417万","url":"https://stock-news.laohu8.com/highlight/detail?id=2641278681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641278681?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:02","pubTimestamp":1780768937,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘,中恒集团报收于2.26元,较上周的2.22元上涨1.8%。本周,中恒集团6月2日盘中最高价报2.31元。中恒集团当前最新总市值71.96亿元,在中药板块市值排名27/66,在两市A股市值排名2547/5206。第4期、第5期欠付款本金及2026年4月30日至5月31日全部剩余欠付款本金对应的利息尚未收到。累计已支付本金37,245.56万元及利息7,550.83万元,尚欠本金387,304,788.11元及相应利息。肇庆高新区土储中心已提供抵押物,公司将继续敦促履约,必要时将采取司法措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0015","BK0239","600252","BK0012","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639160285","title":"每周股票复盘:中恒集团(600252)提名新董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2639160285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639160285?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:32","pubTimestamp":1780173131,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,中恒集团报收于2.22元,较上周的2.21元上涨0.45%。本周,中恒集团5月25日盘中最高价报2.25元。中恒集团当前最新总市值70.69亿元,在中药板块市值排名29/66,在两市A股市值排名2607/5207。公司公告汇总广西梧州中恒集团股份有限公司拟提名刘冬雪女士为公司第十届董事会董事候选人。其任职资格符合相关规定,未受过监管处罚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0077","BK0239","BK0188","600252","BK0028","BK0015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638068607","title":"中恒集团(600252)披露董事候选人提名公告,5月27日股价下跌1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638068607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638068607?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:23","pubTimestamp":1779891797,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘,中恒集团报收于2.18元,较前一交易日下跌1.8%,最新总市值为69.41亿元。该股当日开盘2.21元,最高2.23元,最低2.17元,成交额达7017.2万元,换手率为1.01%。近日,中恒集团发布《2026年第一次临时股东会议案》公告,拟提名刘冬雪女士为公司第十届董事会董事候选人。其任职资格符合相关规定,未受过监管处罚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0239","BK0077","BK0028","BK0015","600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637537543","title":"每周股票复盘:中恒集团(600252)回应ST风险及创新药进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2637537543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637537543?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:01","pubTimestamp":1779566462,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,中恒集团报收于2.21元,较上周的2.26元下跌2.21%。本周,中恒集团5月19日盘中最高价报2.31元。来自公司公告汇总:中恒集团梧州制药(香港)有限公司已完成注销登记。2025年6月13日,中恒集团召开第十届董事会第二十九次会议,审议通过注销中恒集团梧州制药(香港)有限公司的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600252","BK0239","BK1574","BK0077","BK0012","06978","BK0015","BK1161","159992","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637276508","title":"股市必读:中恒集团(600252)5月20日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2637276508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637276508?lang=zh_cn&edition=full","pubTime":"2026-05-21 02:48","pubTimestamp":1779302893,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,中恒集团报收于2.25元,下跌2.17%,换手率0.87%,成交量27.85万手,成交额6272.52万元。来自公司公告汇总:中恒集团梧州制药(香港)有限公司已完成注销登记手续。现场会议于当日10:00在广西南宁市江南区高岭路100号会议室举行。中恒集团梧州制药(香港)有限公司已完成注销。该公司于2025年6月13日经董事会决议注销,近日获香港特别行政区公司注册处核准解散。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100002707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0015","BK0239","BK0077","600252","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636082554","title":"中恒集团(600252)披露梧州制药(香港)公司完成注销公告,5月20日股价下跌2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636082554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636082554?lang=zh_cn&edition=full","pubTime":"2026-05-20 22:36","pubTimestamp":1779287777,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,中恒集团报收于2.25元,较前一交易日下跌2.17%,最新总市值为71.64亿元。近日,广西梧州中恒集团股份有限公司发布《关于中恒集团梧州制药(香港)有限公司完成注销的公告》。公告显示,2025年6月13日,中恒集团召开第十届董事会第二十九次会议,审议通过注销中恒集团梧州制药(香港)有限公司的议案。公司近日收到香港特别行政区公司注册处通知,梧州制药(香港)公司已完成核准解散。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000043481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","01477","BK1574","BK0239","BK0028","BK0012","BK1191","600252","BK0015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636857481","title":"中恒集团(600252)披露关于提名董事候选人的公告,5月19日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636857481","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636857481?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:44","pubTimestamp":1779201855,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,中恒集团报收于2.3元,较前一交易日上涨0.88%,最新总市值为73.24亿元。该股当日开盘2.28元,最高2.31元,最低2.26元,成交额达7194.54万元,换手率为0.99%。近日,广西梧州中恒集团股份有限公司发布《关于召开2026年第一次临时股东会的通知》。本次会议将审议《关于提名刘冬雪女士为公司第十届董事会董事候选人的议案》,中小投资者将对该议案单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900044219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0015","BK0239","BK0077","BK0188","BK0028","600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635009088","title":"中恒集团最新公告:控股孙公司获醋酸曲普瑞林原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2635009088","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635009088?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:11","pubTimestamp":1778839906,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称,公司控股孙公司重庆莱美隆宇药业有限公司收到国家药监局核准签发的醋酸曲普瑞林《化学原料药上市申请批准通知书》。该原料药适用于不育症治疗中的垂体降调节等,有利于丰富公司产品线,提升核心竞争力。截至公告日,除莱美隆宇外,另有10家企业同类原料药已获批上市。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500035164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0015","600252","BK0188","BK0028","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925538","title":"股市必读:中恒集团一季报 - 第一季度单季净利润同比下降292.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925538","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633925538?lang=zh_cn&edition=full","pubTime":"2026-05-06 03:54","pubTimestamp":1778010851,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2026年3月31日,中恒集团股东户数为11.9万户,较2月28日增加194.0户。来自业绩披露要点:中恒集团2026年一季度归母净利润为-3353.06万元,同比下降292.41%。股本股东变化股东户数变动截至2026年3月31日,中恒集团股东户数为11.9万户,较2月28日增加194.0户,增幅0.16%;户均持股数量由上期的2.68万股减少至2.68万股,户均持股市值为6.83万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632647904","title":"每周股票复盘:中恒集团(600252)一季度净亏损3353万","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647904","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632647904?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:23","pubTimestamp":1777666989,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,中恒集团报收于2.46元,较上周的2.48元下跌0.81%。本周,中恒集团4月29日盘中最高价报2.51元。本周关注点业绩披露要点:中恒集团2026年一季报显示归母净利润-3353.06万元,同比下降292.41%。股本股东变化股东户数变动截至2026年3月31日,中恒集团股东户数为11.9万户,较2月28日增加194.0户,增幅0.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","600252","BK0028","BK0012","BK0015","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631131681","title":"中恒集团(600252)3月31日股东户数11.9万户,较上期增加0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631131681","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631131681?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:23","pubTimestamp":1777540985,"startTime":"0","endTime":"0","summary":"证券之星消息,近日中恒集团披露,截至2026年3月31日公司股东户数为11.9万户,较2月28日增加194.0户,增幅为0.16%。在中药行业个股中,中恒集团股东户数高于行业平均水平,截至3月31日,中药行业平均股东户数为5.39万户。从股价来看,2026年2月28日至2026年3月31日,中恒集团区间跌幅为2.67%,在此期间股东户数增加194.0户,增幅为0.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000055496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","600252","BK0015","BK0239","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631540439","title":"图解中恒集团一季报:第一季度单季净利润同比下降292.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631540439","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631540439?lang=zh_cn&edition=full","pubTime":"2026-04-30 02:43","pubTimestamp":1777488192,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团2026年一季报显示,一季度公司主营收入3.55亿元,同比下降31.94%;归母净利润-3353.06万元,同比下降292.41%;扣非净利润-2111.01万元,同比下降241.38%;负债率35.52%,投资收益-1248.69万元,财务费用812.18万元,毛利率52.85%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000007875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630430804","title":"每周股票复盘:中恒集团(600252)完成力合中恒医药基金清算注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2630430804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630430804?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:03","pubTimestamp":1777147395,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,中恒集团报收于2.48元,较上周的2.51元下跌1.2%。本周,中恒集团4月21日盘中最高价报2.53元。中恒集团当前最新总市值78.97亿元,在中药板块市值排名29/66,在两市A股市值排名2464/5200。本周关注点公司公告汇总:广西力合中恒医药投资合伙企业完成清算注销,中恒集团实缴出资2,000.00万元已全部收回。由于基金未开展项目投资,经全体合伙人同意,公司于2025年12月启动清算注销程序。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0015","160635","BK0239","BK0077","600252","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629188247","title":"中恒集团(600252)披露广西力合中恒医药投资合伙企业完成清算注销公告,4月23日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629188247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629188247?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:55","pubTimestamp":1776938129,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘,中恒集团报收于2.48元,较前一交易日下跌0.8%,最新总市值为78.97亿元。该股当日开盘2.51元,最高2.51元,最低2.46元,成交额达5628.1万元,换手率为0.71%。公告显示,公司于2021年6月决定参与投资设立广西力合中恒医药投资合伙企业,认缴出资29,700.00万元,实缴出资2,000.00万元。由于基金未开展项目投资,经全体合伙人同意,公司于2025年12月启动清算注销程序。本次清算注销不会对公司财务状况和日常经营产生实质性影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300049472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0077","BK0188","BK0028","09939","BK1161","BK1515","BK1574","BK0239","BK0015","BK0012","600252"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781375863705,"stockEarnings":[{"period":"1week","weight":-0.0442},{"period":"1month","weight":-0.0809},{"period":"3month","weight":-0.1756},{"period":"6month","weight":-0.2174},{"period":"1year","weight":-0.1818},{"period":"ytd","weight":-0.2117}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广西梧州中恒集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"118957人(较上一季度增加0.16%)","perCapita":"26767股","listingDate":"2000-11-30","address":"广西壮族自治区梧州市万秀区工业园区工业大道1号第1幢","registeredCapital":"318416万元","survey":" 广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。公司荣获华夏医学科学技术奖科技进步奖三等奖、中国中西医结合学会科学技术奖三等奖、广西科技进步奖二等奖各1项,培育1家广西“专精特新”企业,研发综合实力再提升。","listedPrice":5.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中恒集团,600252,中恒集团股票,中恒集团股票老虎,中恒集团股票老虎国际,中恒集团行情,中恒集团股票行情,中恒集团股价,中恒集团股市,中恒集团股票价格,中恒集团股票交易,中恒集团股票购买,中恒集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}